Physician profile
Samuel J Cunningham
NPI 1437193307
$2,719.43
in general payments reported to CMS, 2019-2025
19 companies · $572 in 2025
The $572 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $33.05 · 2021: $210 · 2022: $388 · 2023: $566 · 2024: $588 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,597 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,597.03 |
| Education | $128.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $469.19 | 2019-2024 | Trudi Nav Cable, Relieva Spinplus |
| Glaxosmithkline, LLC. | $397.25 | 2021-2025 | Nucala |
| Genzyme Corporation | $378.21 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $326.05 | 2019-2025 | Dupixent |
| Stryker Corporation | $254.00 | 2019-2023 | Scopis Ent |
| Inspire Medical Systems, INC. | $240.78 | 2024-2025 | Inspire |
| Livanova USA, INC. | $137.70 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Amgen INC. | $96.69 | 2025 | Tezspire |
| Sanofi-Aventis U.S. LLC | $94.99 | 2024 | |
| Optinose US, INC. | $58.80 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $50.57 | 2025 | |
| Medtronic, INC. | $42.65 | 2024-2025 | Novapak, Pteye Parathyroid Detection System |
| Aerin Medical INC. | $41.89 | 2022 | |
| Itamar Medical INC | $34.86 | 2021 | |
| Olympus America INC. | $24.08 | 2023 | Olympus |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $22.47 | 2025 | Xhance |
| Phathom Pharmaceuticals, INC. | $18.67 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $16.20 | 2025 | Bridion |
| Cochlear Americas | $14.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.